Minerva
BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7383.292 (Published 01 February 2003) Cite this as: BMJ 2003;326:292In many countries colorectal cancers are second only to lung cancer as a cause of death from cancer. Prevention is by screening, reduction in exposure to chemical and other environmental agents, and chemoprevention by long term treatment with non-steroidal anti-inflammatory drugs. In studies of patients with arthritis results have shown that the risk of developing bowel cancer and mortality from the disease is lower among those taking such drugs (Cancer Investigation 2002;20:1002-11). The problem is the high frequency of side effects, and the search for safer alternatives continues.
Once colorectal cancer is diagnosed the outlook is still not very good, but in the past 20 years operative mortality has fallen substantially. A study from France of 4745 patients …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.